Outcome of Pregnancy and Labour in a Patient with Hodgkin’s Lymphoma (Clinical Case)
https://doi.org/10.25207/1608-6228-2019-26-4-131-137
Abstract
Background. Hodgkin’s lymphoma (HL) is a malignant disease of lymphoid tissue, which is characterised by the appearance of giant Reed—Berezovsky—Sternberg cells in the lymph nodes affected by the pathological process. These cells can be detected through microscopic examination. Currently, HL is one of the most treatable oncological diseases. In recent years, the recovery rate in patients suffering from this pathology has increased (70–90%), almost reaching the recovery rate in patients starting treatment at the early stages. Given the above, the quality of life in these patients during remission is becoming more important, since most of them are women of childbearing age planning to have children. In this connection, it is of great importance to study the course of pregnancy and labour, along with their effect on the possibility of a relapse, in such patients.
Aim. In this paper, we set out to analyse the course of pregnancy and childbirth in a patient suffering from HL.
Materials and methods. We studied the medical records (including medical history and pregnancy records) of a patient whose pregnancy occurred in the setting of a severe oncological pathology – HL in remission. The patient underwent a thorough examination and the baby was successfully delivered.
Result. The outcome of pregnancy and childbirth for the patient and foetus was studied in the setting of a severe oncological pathology (HL in remission).
Conclusion. The pregnancy of a woman suffering from a serious oncological pathology (HL in remission) was prolonged to full-term and successfully completed. The patient was able to experience the joy of motherhood for the third time.
About the Authors
A. A. BorschevaRussian Federation
Alla A. Borscheva* — Cand. Sci. (Med.), Assoc. Prof., Department of Obstetrics and Gynecology No. 1
Bratskiy per., 48-13, Rostov-on-Don, 344082
G. M. Pertseva
Russian Federation
Galina M. Pertseva — Cand. Sci. (Med.), Research Assistant, Department of Obstetrics and Gynecology No. 1
Nakhichevansky str., 29, Rostov-on-Don, 344022
References
1. Pavlov V.V., Bogatyreva T.N., Shakhtarina S.V., Danilenko A.A. Optimizatsiya luchevogo komponenta v programmakh kombinirovannogo khimioluchevogo lecheniya bol’nykh limfomoi Khodzhkina. V kn.: Tsyba A.F., Mardynskii Yu.S., redaktory. Terapevticheskaya radiologiya [Therapeutic radiology]. Moscow: Meditsinskaya kniga; 2010. 461–504. (In Russ.).
2. Shklyaev S.S., Pavlov V.V. Hodgkin’s lymphoma and a “new old” bendamustine. Klinicheskaya onkogematologiya. 2013; 6(2): 139–147. (In Russ., English abstract).
3. Holmberg L., Maloney D.G. The role of autologous and allogeneic hematopoietic stem cell transplantation for Hodgkin lymphoma. J. Natl. Compr. Canc. Netw. 2011; 9(9): 1060–1071.
4. Bogatyreva T., Pavlov V., Shklyaev S. Recurrent Hodgkin’s lymphoma: possibilities for prolonging life without high-dose chemotherapy. Vrach. 2012; 11: 5–8. (In Russ., English abstract).
5. Anderson R.A., Brewster D.H., Wood R., Nowell S., Fischbacher C., Kelsey T.W., Wallace W.H.B. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod. 2018; 33(7): 1281–1290. DOI: 10.1093/humrep/dey216
6. Kroll-Balcerzak R., Baranska M., Gil L., Kazmierczak M., Balcerzak A., Izycki D. Hodgkin lymphoma in pregnancy — current management practice based on case report series. Ginekol. Pol. 2019; 90(4): 233–234. DOI: 10.5603/GP.2019.0042
7. Gaudio F., Nardelli C., Masciandaro P. , Perrone T. , Laddaga F.E., Curci P., Depalo R. , Cicinelli E., Specchia G. Pregnancy rate and outcome of pregnancies in long-term survivors of Hodgkin’s lymphoma. Ann. Hematol. 2019; 98(8): 1947–1952. DOI: 10.1007/s00277-019-03684-0
8. Wheaton L., Alexander S. Pregnancy screening and contraceptive counseling in young women with hodgkin lymphoma: a single center retrospective review. J Adolesc. Young. Adult. Oncol. 2019; 8(3): 349–353. DOI: 10.1089/jayao.2018.0156
9. Alami Z., Bouhafa T., Elmazghi A., Hassouni K. Therapeutic approach against malignant Hodgkin’s lymphoma during pregnancy: about a case and literature review. Pan. Afr. Med. J. 2018; 30: 20. DOI: 10.11604/pamj.2018.30.20.14662
10. Møller H., Purushotham A., Linklater K.M., Garmo H., Holmberg L., Lambe M., Yallop D., Devereux S. Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma. Eur. J. Cancer. 2013; 49(17): 3686–3693. DOI: 10.1016/j.ejca.2013.06.047
11. Corazzelli G., Angrilli F., D’Arco A., Ferrara F., Musto P., Guarini A., Cox M.C., Stelitano C., Storti S., Iannitto E., Falorio S., Califano C., Amore A., Arcamone M., De Filippi R., Pinto A. Effi cacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma. Br. J. Haematol. 2013; 160(2): 207–215. DOI: 10.1111/bjh.12120
12. Boltežar L., Pintarić K., Jezeršek Novaković B. Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey. J. Assist. Reprod. Genet. 2016; 33(3): 325–333. DOI: 10.1007/s10815015-0636-6
13. Connors J.M. I. Hodgkin lymphoma: special challenges and solutions. Hematol. Oncol. 2015; 33(Suppl 1): 21–24. DOI: 10.1002/hon.2210
14. Peccatori F.A., Azim H.A. Jr, Orecchia R., Hoekstra H.J., Pavlidis N., Kesic V., Pentheroudakis G.; ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013; 24(Suppl 6): vi160–70. DOI: 10.1093/annonc/mdt199
15. Moshe Y., Bentur O.S., Lishner M., Avivi I. The management of Hodgkin lymphomas in pregnancies. Eur. J. Haematol. 2017; 99(5): 385–391. DOI: 10.1111/ejh.12956
Review
For citations:
Borscheva A.A., Pertseva G.M. Outcome of Pregnancy and Labour in a Patient with Hodgkin’s Lymphoma (Clinical Case). Kuban Scientific Medical Bulletin. 2019;26(4):131-137. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-4-131-137